Apollon Papadimitriou
Algemeen Directeur bij iOmx Therapeutics AG
Profiel
Apollon Papadimitriou is currently the Chief Executive Officer at iOmx Therapeutics AG.
He started this position in 2019.
Prior to his current role, he obtained a doctorate degree from Julius-Maximilians-Universität Würzburg in 1995.
Actieve functies van Apollon Papadimitriou
| Bedrijven | Functie | Begin |
|---|---|---|
iOmx Therapeutics AG
 iOmx Therapeutics AG BiotechnologyHealth Technology iOmx Therapeutics AG develops immunotherapy treatments for cancer patients. It specializes in immuno oncology, drug development and cancer therapy. The company was founded by Nisit Khandelwal, Philipp Beckhove, Patrick Baeuerle, Sebastian Meier-Ewert and Elmar Maier in March 2016 and is headquartered in Munich, Germany. | Algemeen Directeur | 01-07-2019 |
Opleiding van Apollon Papadimitriou
| Julius-Maximilians-Universität Würzburg | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
iOmx Therapeutics AG
iOmx Therapeutics AG BiotechnologyHealth Technology iOmx Therapeutics AG develops immunotherapy treatments for cancer patients. It specializes in immuno oncology, drug development and cancer therapy. The company was founded by Nisit Khandelwal, Philipp Beckhove, Patrick Baeuerle, Sebastian Meier-Ewert and Elmar Maier in March 2016 and is headquartered in Munich, Germany. | Health Technology |
